title: Optimization of doses received by the hospital staff and the members of the family of patients undergoing 111In-DTPA-D-Phe1-Octreotide therapy.
abstract: According to the Euratom Directives (96/29, 97/43), the doses received by the workers as well as the family of patients and third persons during medical exposures, should conform to the dose constraint levels (DCLs), established by the authorities for each group in the context of optimisation. This study deals with the implementation of a radiation protection protocol, concerning the aforementioned group members for patients undergoing treatment with 111In-DTPA-D-Phe1-Octreotide, after intra-arterial infusion. It is shown that by applying this protocol the annual doses to the medical and technical staff are considerably reduced and remain below the established DCLs. Following the post-release behaviour instructions given to the patient, doses to the family and third persons may be kept lower than the corresponding DCLs provided by the National Regulations.
authors.affiliation: Nuclear Medicine Division, Radiology Department, Aretaieion University Hospital, Vas. Sophias Avenue 76, 11528 Athens, Greece.
authors.forename: D
authors.initials: D
authors.lastname: Kontogeorgakos
authors.forename: G S
authors.initials: GS
authors.lastname: Limouris
authors.forename: V
authors.initials: V
authors.lastname: Kamenopoulou
authors.forename: E
authors.initials: E
authors.lastname: Carinou
authors.forename: G
authors.initials: G
authors.lastname: Papanikolos
authors.forename: L
authors.initials: L
authors.lastname: Vlahos
authors.forename: P
authors.initials: P
authors.lastname: Dimitriou
mesh_terms: D004867:Equipment Design; D019544:Equipment Failure Analysis; D005190:Family; D006115:Greece; D038622:Internationality; D008503:Medical Staff; D016273:Occupational Exposure / Q000032:analysis*; D004369:Pentetic Acid / Q000031:analogs & derivatives* / Q000032:analysis / Q000627:therapeutic use; D011829:Radiation Dosage; D011834:Radiation Monitoring / Q000379:methods*; D011835:Radiation Protection / Q000379:methods*; D019275:Radiopharmaceuticals / Q000032:analysis* / Q000627:therapeutic use; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity
chemical_list: C442550:(111)indium-DTPA-D-phe octreoide; D019275:Radiopharmaceuticals; D004369:Pentetic Acid